Vanguard Capital Management
KALA icon

Vanguard Capital Management’s KALA BIO KALA Stock Holding History

Vanguard Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Buy
220,623
+219,412
+18,118% +$1.06M ﹤0.01% 3752
2026
Q1 		$10.5K Buy
+1,211
New +$25.6K ﹤0.01% 4016

Other funds holding KALA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management's KALA Position: Q2 2026 in Review

Vanguard Capital Management increased its KALA BIO (KALA) stake by 18,118% in Q2 2026, buying an estimated $1.06M and bringing the position to 220,623 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #3752.

Vanguard Capital Management first reported a position in KALA in Q1 2026 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.

  • Vanguard Capital Management held 220,623 shares of KALA BIO worth $382K as of Q2 2026.
  • Vanguard Capital Management bought 219,412 KALA BIO shares in Q2 2026, an estimated $1.06M.
  • KALA BIO made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3752 holding.
  • Vanguard Capital Management first reported a position in KALA BIO in Q1 2026 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.